Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02895087 · ClinicalTrials.gov registry record
Study to Explore Natural Daily Variation and Impact of Stress in HIV Levels
A clinical trial, sponsored by University of Melbourne.
- Completed
- Registry status
- 40
- Enrollment target
NCT02895087: Completed study, sponsored by University of Melbourne.
NCT02895087 is a clinical trial that has completed, run by University of Melbourne. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02895087 has completed, sponsored by University of Melbourne.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
Despite advances in AntiRetroviral Therapy (ART) leading to a rapid control of the HIV virus in individuals affected, HIV can persist indefinitely and there is no cure. The HIV virus has been shown to have a unique ability to hide within the human gene inside human cells and in tissues, remaining 'silent' and rapidly reactivate 'waking up" if ART is stopped. There are a number of ways to measure the silent HIV reservoir, including a common research-based laboratory test called Cell-Associated UnSpliced (CA-US) HIV RNA. This is an early marker of the HIV virus waking up. It is often used to test how well new drugs developed to eliminate the silent virus might work. This study is examining whether the diurnal variation (daily rhythm) and/or stress can affect CA-US HIV RNA levels in individuals diagnosed with HIV and receiving ART.
Primary Outcome
To determine if there are diurnal variations in cortisol and catecholamine in HIV transcription in latently-infected cells in HIV-infected participants on ART.
Interventions
- OTHER Diurnal Variation Group
- OTHER External Stress Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-03 |
| Est. Completion | 2018-01 |
What the finished NCT02895087 record still lists
NCT02895087 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Diurnal Variation Group is the first listed.
NCT02895087 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02895087 about?
NCT02895087 is a clinical study titled "Study to Explore Natural Daily Variation and Impact of Stress in HIV Levels". Despite advances in AntiRetroviral Therapy (ART) leading to a rapid control of the HIV virus in individuals affected, HIV can persist indefinitely and there is no cure. The HIV virus has been shown to have a unique ability to hide within the human gene inside human cells and in tissues, remaining 's...
What is the current status of trial NCT02895087?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2015-03. Estimated completion is 2018-01.
What interventions are being tested in trial NCT02895087?
The interventions under investigation include: Diurnal Variation Group (OTHER), External Stress Group (OTHER).
Who is sponsoring clinical trial NCT02895087?
This trial is sponsored by University of Melbourne, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia